Skaana Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Skaana Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,288	Closed	-$11.4K	–	197
2023 Q4	$11.4K	Hold	23,288	–	–	﹤0.01%	139
2023 Q3	$3.96K	Hold	23,288	–	–	﹤0.01%	147
2023 Q2	$4.42K	Hold	23,288	–	–	﹤0.01%	152
2023 Q1	$2.56K	Buy	+23,288	New	+$4.49K	﹤0.01%	139

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Skaana Management's RCKTW Position: Q1 2024 in Review

Skaana Management sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q1 2024, closing a stake of 23,288 shares — an estimated $11.4K sold.

Skaana Management first reported a position in RCKTW in Q1 2023 and held it in 4 quarters. The position peaked at $11.4K in Q4 2023. 15 funds tracked by Wall St. Rank hold RCKTW as of Q1 2024.

Skaana Management reported no remaining Rocket Pharmaceuticals Warrant position as of Q1 2024 after selling out during the quarter.
Skaana Management sold 23,288 Rocket Pharmaceuticals Warrant shares in Q1 2024, an estimated $11.4K.
Skaana Management first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and held it in 4 quarters.
Skaana Management's Rocket Pharmaceuticals Warrant position peaked at $11.4K in Q4 2023.
15 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2024.

Based on Skaana Management's 13F filing for Q1 2024, filed 14 May 2024.